France Alport Syndrome Therapeutics Market Report 2023 to 2030

France Alport Syndrome Therapeutics Market Analysis

$ 3999

France during the forecast period of 2023-30, the Alport Syndrome therapeutics market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. Almost always affecting the kidney, Alport syndrome is a multisystem condition that also usually affects the inner ear and the eye. A variety of symptoms that normally start in childhood or adolescence and may get worse over time can be present. Invitae Corporation, Hoffmann-La Roche Ltd., Centogene N.V., and Eurofins Discovery are a few of the leading companies in the worldwide Alport syndrome market.

ID: IN10FRRD003 CATEGORY: Rare Diseases GEOGRAPHY: France AUTHOR: Nipun Arora

Buy Now

France Alport Syndrome Therapeutics Market Analysis Summary

France Alport Syndrome Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $6.43 Mn by 2030, exhibiting a CAGR of 6.1% during the forecast period 2023-2030.

In addition to kidney failure, hearing loss, and vision issues, Alport syndrome is an uncommon hereditary illness. Genes COL4A3, COL4A4, and COL4A5, which are important in the manufacture of proteins like type IV collagen, are mutated, and this disorder is the result. The number of Americans with this condition is less than 50,000.

Nerve deafness in various degrees was one of the most notable extrarenal symptoms mentioned by Alport. The diagnosis of the ailment is made using the patient's family history, clinical symptoms, and specialised testing, such as kidney biopsy. Genetic testing can formally establish the diagnosis. In addition to having nerve deafness, their urine also included blood and protein, however, the degree of these conditions varied between family members.

Increased mortality owing to end-stage disease was another characteristic of affected members.

The two Col4a5 models' X-linked nature predicts a gender skew in the disease's severity and course. Another autosomal kidney disorder with a sex-dependent pattern is polycystic kidney disease. More people with less severe types of Alport syndrome are being found, though, as research into the disorder continues. Future possibilities include exon skipping, chaperones, protein replacement therapy, genome editing, premature termination codon readthrough therapy, stem cell transplantation, and many more. In the ongoing proof-of-concept Phase 2 open-label clinical trial (NCT05448755) in up to eight Alport syndrome patients with nonsense mutations in the Collagen Type 4 genes, Eloxx has now dosed three patients with ELX-02 (COL4A3, COL4A4, and COL4A5). One patient's first decrease in proteinuria was encouraging. Increased prevalence and funding and adoption of home care settings have boosted the Alport Syndrome Therapeutics Market. Invitae Corporation, Hoffmann-La Roche Ltd., Centogene N.V., and Eurofins Discovery are a few of the leading companies in the worldwide Alport syndrome market.

Market Dynamics

Market Growth Drivers

Increased prevalence of syndrome: The COL4A5 gene, which is found on the X chromosome, has mutations that account for about 80% of instances of Alport syndrome. This contributes to the market's growth
Increased emphasis on diagnosis: Early indications of Alport syndrome are diagnosed using skin and kidney biopsies, and the faster adoption of these diagnostic methods is a key factor driving the global market
Increased funding on R&D: To encourage researchers and pharmaceutical companies to develop advanced medicines, the government is funding R&D initiatives
High adoption of home care settings: High adoption of home care settings has also encouraged the alport syndrome therapeutics market

Market Restraints

Companies are concentrating on clinical trials for the development of drugs for the disease because there is no particular treatment for Alport syndrome. The high expense of development is an additional difficulty.

Key players

Otsuka Pharmaceutical Astellas Pharma Alexion Pharmaceuticals CSL Behring Kedrion Biopharma Baxter International GlycoMimetics Vir Biotechnology Intercept Pharmaceuticals Alnylam Pharmaceuticals

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

??France Alport Syndrome Therapeutics Market Segmentation

Genetic Type

X-linked Alport Syndrome
Autosomal Recessive Alport Syndrome
Autosomal Dominant Alport Syndrome
Others

Diagnosis

Urine analysis
Creatinine clearance test
GFR estimation
Kidney biopsy
Genetic testing
Ear examination
Eye examination

Treatment

Medication
ACE Inhibitors
Angiotensin -II receptor blockers
Sodium-glucose transport type 2 inhibitor
RAAS inhibition
Others
Surgery
Dietary control
Others

End-Users

Hospitals
Specialty Clinics
Others

Distribution Channel

Hospitals
Pharmacy
Others

Route of Administration

Oral
Parenteral
Others

Dosage form

Tablet
Capsule
Injectables
Others

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.